← Back to headlines
Guardant Health Ordered to Pay $245 Million in DNA Sequencing Patent Lawsuit
A court has ruled that Guardant Health must pay $245 million to resolve a patent dispute over DNA sequencing technology, marking a significant legal victory for the opposing party.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
